Downs Christopher has filed 6 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 4881 shares of CNS Pharmaceuticals, Inc. ($CNSP) on November 17, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 17, 2025 | CNS Pharmaceuticals, Inc. | $CNSP | Downs Christopher | Chief Financial Officer | A | Option to purchase common stock | 4881 | $0.00 | 4,881.0000 | 620,290 | 9999.99% | 0.79% |
| April 8, 2024 | CNS Pharmaceuticals, Inc. | $CNSP | Downs Christopher | Chief Financial Officer | A | Option to purchase common stock | 40000 | $0.00 | 201.5720 | 0 | 0.00% | 0.00% |
| April 8, 2024 | CNS Pharmaceuticals, Inc. | $CNSP | Downs Christopher | Chief Financial Officer | A | Restricted Stock Units | 40000 | $0.00 | 241.5720 | 0 | 0.00% | 0.00% |
| Feb. 1, 2024 | CNS Pharmaceuticals, Inc. | $CNSP | Downs Christopher | Chief Financial Officer | P | Common stock | 66666 | $0.30 | 103,438.0000 | 0 | 181.30% | 0.00% |
| Feb. 1, 2024 | CNS Pharmaceuticals, Inc. | $CNSP | Downs Christopher | Chief Financial Officer | A | Series A Warrant to purchase common stock | 66666 | $0.00 | 94,906.0000 | 0 | 236.07% | 0.00% |
| Feb. 1, 2024 | CNS Pharmaceuticals, Inc. | $CNSP | Downs Christopher | Chief Financial Officer | A | Series B Warrant to purchase common stock | 66666 | $0.00 | 161,572.0000 | 0 | 70.24% | 0.00% |